Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately after Induction Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer

Jean Louis Pujol, Luis Paz-Ares, Filippo De Marinis, Mircea Dediu, Michael Thomas, Paolo Bidoli, Jesus Corral, Belen San Antonio, Nadia Chouaki, William John, Annamaria Zimmermann, Carla Visseren-Grul, Cesare Gridelli

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately after Induction Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences